Background: Patients with chronic diseases face increased risks from vaccine-preventable diseases, including influenza and herpes zoster. The concurrent administration of influenza and herpes zoster vaccines presents an opportunity to improve vaccination coverage while reducing healthcare visits. Objective: To systematically review the literature on the safety, immunogenicity, and efficacy of concurrent administration of influenza and herpes zoster vaccines in patients with chronic diseases. Methods: A comprehensive literature review was conducted using PubMed, MEDLINE, and Cochrane databases, focusing on studies published between 2006-2023. Search terms included "influenza vaccine," "herpes zoster vaccine," "concurrent administration," "coadministration," and "chronic disease." Results: Multiple randomized controlled trials and observational studies demonstrate that concurrent administration of influenza and herpes zoster vaccines is safe and immunogenic in chronic disease populations. The Zoster-039 study (n=828) showed non-inferior immune responses when vaccines were given concomitantly versus separately. Safety profiles were comparable between concurrent and separate administration groups across multiple studies involving diabetic, cardiovascular, and COPD patients. Conclusions: Concurrent administration of influenza and herpes zoster vaccines is safe, immunogenic, and effective in chronic disease patients. Current evidence supports this practice as recommended by major health organizations, with potential benefits including improved vaccination coverage and reduced healthcare burden.